Foxo Technologies Investor Relations Material
Latest events
Q2 2023
Foxo Technologies
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Foxo Technologies Inc
Access all reports
Foxo Technologies Inc. is a biotechnology company focused on using epigenetic science and artificial intelligence to develop advanced health and longevity solutions. The company integrates molecular biotechnology with data analytics to offer innovative products in the life insurance and health sectors. Foxo's platform is designed to leverage epigenetic biomarkers to assess biological aging and health risks, aiming to transform underwriting processes in the life insurance industry. The company’s work in epigenetics seeks to provide more personalized insights into health and wellness. The company is headquartered in Minneapolis, Minnesota, and its shares are listed on the NYSE.
Latest articles
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
Rocket Lab: Breaking Ground in Space
Rocket Lab has been one of the pioneers in the commercial aerospace industry, with numerous satellite launches and space system applications.
9 Dec 2024
Ticker symbol
FOXO
Country
🇺🇸 United States